Acceleron Pharma reported $91.6M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Akebia Therapeutics AKBA:US $ 79.76M 37.48M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Amgen AMGN:US $ 5.7B 1.93B
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
Bayer BAYN:GR 13.14B 3.89B
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Clovis Oncology CLVS:US $ 94.4M 1.66M
Dicerna Pharmaceuticals DRNA:US $ 81.58M 4.87M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Exelixis EXEL:US $ 262.17M 12.67M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NOVN:VX 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Puma Biotechnology PBYI:US $ 55.11M 23.09M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Rigel Pharmaceuticals RIGL:US $ 39.31M 51K
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Tg Therapeutics TGTX:US $ 79.04M 10.96M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
United Therapeutics UTHR:US $ 226.6M 217.3M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M